Compare Enveric Biosciences Inc (ENVB) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs iShares Silver Trust — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while iShares Silver Trust trades at $50.37. The key difference: iShares Silver Trust is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SLV | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $105.57 |
52-Week Low | $1.28 | $33.32 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The iShares Silver Trust (SLV) is trading at $50.46, down 5.1% over 24 hours, reflecting significant near-term pressure on silver prices. Technical indicators show a bearish consensus with moving averages signaling strong selling pressure, though short-term RSI levels suggest potential oversold conditions. Recent news highlights silver's dual role as both a monetary and industrial metal, with analysts noting persistent supply deficits and rising demand that could support longer-term appreciation.
The outlook for SLV is challenged by near-term bearish technicals and macroeconomic headwinds, including inflation concerns and Federal Reserve policy uncertainty. However, structural supply-demand dynamics and silver's industrial applications in green technologies present a potential recovery catalyst. Investors face volatility from commodity price swings and competing ETF options with lower fees, requiring careful risk assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
